|
¾ÆÁÖ¾àÇ°(ÁÖ) |
¾ÆÁÖ¾àÇ°¢ß °Ç°±â´É½ÄÇ° ºê·£µå¸Å´ÏÀú °æ·Â»ç¿ø ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
5³â¡è |
04.22 |
04.08 |
|
|
¾Ëº¸Á¨ ÄÚ¸®¾Æ ÁÖ½Äȸ»ç |
Senior RA Specialist (°æ·Â 5³â ÀÌ»ó)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
04.30 |
04.08 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
Obesity Medical Representative, Daegu & Gyeongbuk (1 yea
´ë±¸ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
04.08 |
|
|
´º·ÎÇÍ ÁÖ½Äȸ»ç |
ÇØ¿Ü¿µ¾÷
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
04.15 |
|
|
¹ÙÀÌÅ»¿¡¾îÄÚ¸®¾Æ |
ÀÇ·á±â±â ·ÎÄà º´¿ø ¿µ¾÷ (´ëÀü)
´ëÀü ¼±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
03.05 |
|
|
¼¼ºñ¾ÆÄÚ¸®¾Æ À¯ÇÑȸ»ç |
[Sebia KOrea Ltd.] Territory Manager
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
5³â¡è |
ä¿ë½Ã |
02.19 |
|
|
¾Ëº¸Á¨ ÄÚ¸®¾Æ ÁÖ½Äȸ»ç |
[¾Ëº¸Á¨ÄÚ¸®¾Æ] OPERATION QA Manager
°æ±â ȼº½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
02.20 |
|
|
Novotech |
[³ëº¸ÅØ] Associate Director, Regulatory Operations ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
10³â¡è |
ä¿ë½Ã |
02.26 |
|
|
Novotech |
[Novotech] Business Development Manager ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
04.04 |
|
|
ÁÖ½Äȸ»ç ÇÑâ¸Þµñ |
(ÁÖ)ÇÑâ¸Þµñ Ç°ÁúÆÀ ä¿ë °ø°í
Ãæ³² ¾Æ»ê½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
02.14 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
[±Û·Î¹ú Á¦¾à»ç] Medical Advisor, Liver Disease (Metaboli
¼¿ï ¼ÛÆı¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
6³â¡è |
ä¿ë½Ã |
12.15 |
|
|
¹ÙÀÌ¿À¼Ö·ç¼Ç |
(ÁÖ)¹ÙÀÌ¿À¼Ö·ç¼Ç ¹ÙÀÌ¿ÀÀ¶ÇÕ¼ÒÀç»ç¾÷ºÎ ¿µ¾÷Á÷ ä¿ë (ÆÀÀå
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°ø°³Ã¤¿ë |
10³â¡è |
ä¿ë½Ã |
11.28 |
|
|
(ÁÖ)´Ùº¹¸ÞµðÄ® |
[¾È¾ç/¹Ú´Þµ¿]ȸ°è °æ·Â ä¿ë
°æ±â ¾È¾ç½Ã ¸¸¾È±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
5³â¡è |
ä¿ë½Ã |
11.22 |
|
|
(ÁÖ)´Ùº¹¸ÞµðÄ® |
¿µ¾÷°ü¸®/°ü¸®ÆÄÆ® ä¿ë
°æ±â ¾È¾ç½Ã ¸¸¾È±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
5³â¡è |
»ó½Ãä¿ë |
11.22 |
|
|
(ÁÖ)»þÆä·Ð |
Çõ½Å½Å¾à¿¬±¸¼¾ÅÍ ¿¬±¸±âȹ ÆÀÀå
¼¿ï °³²±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
12.06 |
|